{"pmid":32374537,"title":"[SARS-CoV-2, a point in the storm].","text":["[SARS-CoV-2, a point in the storm].","Since its emergence in December 2019, scientific knowledge about the SARS-CoV-2 virus has evolved rapidly but, due to the complexity and novelty of this infection and its political and economic stakes, much remains to be clarified. Thousands of studies have already been published and scientific research is constantly evolving. In this multitude of information, we offer an update of the knowledge currently available. A limitation of the propagation, the understanding of the functioning of the virus and its clinical manifestations, the administration of specific treatments, rapid and reliable diagnostic tools are the basis of the fight against this germ, which is still little known today.","Rev Med Suisse","Tadini, Eliana","Papamidimitriou-Olivgeris, Matthaios","Opota, Onya","Moulin, Estelle","Lamoth, Frederic","Manuel, Oriol","Lhopitallier, Loic","Jaton, Katia","Croxatto, Antony","Grandbastien, Bruno","Senn, Laurence","Guery, Benoit","32374537"],"abstract":["Since its emergence in December 2019, scientific knowledge about the SARS-CoV-2 virus has evolved rapidly but, due to the complexity and novelty of this infection and its political and economic stakes, much remains to be clarified. Thousands of studies have already been published and scientific research is constantly evolving. In this multitude of information, we offer an update of the knowledge currently available. A limitation of the propagation, the understanding of the functioning of the virus and its clinical manifestations, the administration of specific treatments, rapid and reliable diagnostic tools are the basis of the fight against this germ, which is still little known today."],"journal":"Rev Med Suisse","authors":["Tadini, Eliana","Papamidimitriou-Olivgeris, Matthaios","Opota, Onya","Moulin, Estelle","Lamoth, Frederic","Manuel, Oriol","Lhopitallier, Loic","Jaton, Katia","Croxatto, Antony","Grandbastien, Bruno","Senn, Laurence","Guery, Benoit"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374537","source":"PubMed","week":"202019|May 04 - May 10","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138496440467457,"score":9.490897,"similar":[{"pmid":32298415,"pmcid":"PMC7184418","title":"COVID-19 outbreak in Italy: protecting worker health and the response of the Italian Industrial Hygienists Association.","text":["COVID-19 outbreak in Italy: protecting worker health and the response of the Italian Industrial Hygienists Association.","The number of people infected with severe acute respiratory syndrome - coronavirus 2 (SARS-CoV-2), i.e. the virus causing coronavirus disease (COVID-19), is dramatically increasing worldwide to the size of a pandemic. At the time of writing Italy is ranking first among countries both in terms of number of COVID-19 confirmed cases and in terms of number of deaths. Such a wide spread of COVID-19 has led to concern among workers who are facing the risk of becoming infected during the execution of their duties. We believe it is useful to remark on the need for professional expertise in the field of Occupational Hygiene in this emergency context, in which the indications provided by national and international bodies, the available scientific literature and the legal provisions are constantly and rapidly evolving. It is of fundamental importance that there is an effective analysis of expert inputs, to provide essential guidance to Health, Safety and Environmental managers and other prevention managers in workplaces. In this regard, not only a constant update of the regulatory framework is needed, but also a development and circulation of operational guidance to all the stakeholders to translate general indications into clear operating procedures and implementation tools to be adopted in the workplaces. We believe that the scientific associations in the field of Occupational Hygiene play a crucial role in guiding and assisting prevention professionals. There is considerable expertise in the occupational hygiene and exposure science communities that can help employers and workers to contain and delay the spread of Covid-19. For this reason, the Italian Association of Industrial Hygienists (AIDII - Associazione Italiana degli Igienisti Industriali) published documents containing operational guidelines to provide correct and constantly updated information for: (1) workers employed in essential activities (with low and medium risk of contagion), (2) health workers and other workers at high or very high risk of contagion, and (3) for the correct use and handling of personal protective equipment (PPE) for workers and for the population in general. It is worth pointing out that the documents produced are not intended to replace those produced by authoritative bodies, but to comply with and complete them by reporting an effective summary and further indications about the measures that should be taken in practice under the light of the Italian legislation. At present, the challenge is to produce scientifically-sound knowledge, appropriate tools and effective methodologies, by coordinating the initiatives of different scientific associations, with the final aim to effectively transfer them to employers and workers.","Ann Work Expo Health","Spinazze, Andrea","Cattaneo, Andrea","Cavallo, Domenico M","32298415"],"abstract":["The number of people infected with severe acute respiratory syndrome - coronavirus 2 (SARS-CoV-2), i.e. the virus causing coronavirus disease (COVID-19), is dramatically increasing worldwide to the size of a pandemic. At the time of writing Italy is ranking first among countries both in terms of number of COVID-19 confirmed cases and in terms of number of deaths. Such a wide spread of COVID-19 has led to concern among workers who are facing the risk of becoming infected during the execution of their duties. We believe it is useful to remark on the need for professional expertise in the field of Occupational Hygiene in this emergency context, in which the indications provided by national and international bodies, the available scientific literature and the legal provisions are constantly and rapidly evolving. It is of fundamental importance that there is an effective analysis of expert inputs, to provide essential guidance to Health, Safety and Environmental managers and other prevention managers in workplaces. In this regard, not only a constant update of the regulatory framework is needed, but also a development and circulation of operational guidance to all the stakeholders to translate general indications into clear operating procedures and implementation tools to be adopted in the workplaces. We believe that the scientific associations in the field of Occupational Hygiene play a crucial role in guiding and assisting prevention professionals. There is considerable expertise in the occupational hygiene and exposure science communities that can help employers and workers to contain and delay the spread of Covid-19. For this reason, the Italian Association of Industrial Hygienists (AIDII - Associazione Italiana degli Igienisti Industriali) published documents containing operational guidelines to provide correct and constantly updated information for: (1) workers employed in essential activities (with low and medium risk of contagion), (2) health workers and other workers at high or very high risk of contagion, and (3) for the correct use and handling of personal protective equipment (PPE) for workers and for the population in general. It is worth pointing out that the documents produced are not intended to replace those produced by authoritative bodies, but to comply with and complete them by reporting an effective summary and further indications about the measures that should be taken in practice under the light of the Italian legislation. At present, the challenge is to produce scientifically-sound knowledge, appropriate tools and effective methodologies, by coordinating the initiatives of different scientific associations, with the final aim to effectively transfer them to employers and workers."],"journal":"Ann Work Expo Health","authors":["Spinazze, Andrea","Cattaneo, Andrea","Cavallo, Domenico M"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298415","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1093/annweh/wxaa044","keywords":["covid-19","sars-cov-2","occupational health","occupational hygiene","workers' health"],"locations":["Italy","Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493276913665,"score":87.77671},{"pmid":32218151,"title":"Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.","text":["Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.","During its first two and a half months, the recently emerged 2019 novel coronavirus, SARS-CoV-2, has already infected over one-hundred thousand people worldwide and has taken more than four thousand lives. However, the swiftly spreading virus also caused an unprecedentedly rapid response from the research community facing the unknown health challenge of potentially enormous proportions. Unfortunately, the experimental research to understand the molecular mechanisms behind the viral infection and to design a vaccine or antivirals is costly and takes months to develop. To expedite the advancement of our knowledge, we leveraged data about the related coronaviruses that is readily available in public databases and integrated these data into a single computational pipeline. As a result, we provide comprehensive structural genomics and interactomics roadmaps of SARS-CoV-2 and use this information to infer the possible functional differences and similarities with the related SARS coronavirus. All data are made publicly available to the research community.","Viruses","Srinivasan, Suhas","Cui, Hongzhu","Gao, Ziyang","Liu, Ming","Lu, Senbao","Mkandawire, Winnie","Narykov, Oleksandr","Sun, Mo","Korkin, Dmitry","32218151"],"abstract":["During its first two and a half months, the recently emerged 2019 novel coronavirus, SARS-CoV-2, has already infected over one-hundred thousand people worldwide and has taken more than four thousand lives. However, the swiftly spreading virus also caused an unprecedentedly rapid response from the research community facing the unknown health challenge of potentially enormous proportions. Unfortunately, the experimental research to understand the molecular mechanisms behind the viral infection and to design a vaccine or antivirals is costly and takes months to develop. To expedite the advancement of our knowledge, we leveraged data about the related coronaviruses that is readily available in public databases and integrated these data into a single computational pipeline. As a result, we provide comprehensive structural genomics and interactomics roadmaps of SARS-CoV-2 and use this information to infer the possible functional differences and similarities with the related SARS coronavirus. All data are made publicly available to the research community."],"journal":"Viruses","authors":["Srinivasan, Suhas","Cui, Hongzhu","Gao, Ziyang","Liu, Ming","Lu, Senbao","Mkandawire, Winnie","Narykov, Oleksandr","Sun, Mo","Korkin, Dmitry"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32218151","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.3390/v12040360","keywords":["2019 novel coronavirus","2019-ncov","covid-19","sars-cov-2","interactome","protein-protein interactions","structural genomics"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490488750080,"score":87.315186},{"pmid":32209231,"pmcid":"PMC7094376","title":"Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.","text":["Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.","This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19. This is to find a short section or sections of viral protein sequence suitable for preliminary design proposal for a peptide synthetic vaccine and a peptidomimetic therapeutic, and to explore some design possibilities. The project was originally directed towards a use case for the Q-UEL language and its implementation in a knowledge management and automated inference system for medicine called the BioIngine, but focus here remains mostly on the virus itself. However, using Q-UEL systems to access relevant and emerging literature, and to interact with standard publically available bioinformatics tools on the Internet, did help quickly identify sequences of amino acids that are well conserved across many coronaviruses including 2019-nCoV. KRSFIEDLLFNKV was found to be particularly well conserved in this study and corresponds to the region around one of the known cleavage sites of the SARS virus that are believed to be required for virus activation for cell entry. This sequence motif and surrounding variations formed the basis for proposing a specific synthetic vaccine epitope and peptidomimetic agent. The work can, nonetheless, be described in traditional bioinformatics terms, and readily reproduced by others, albeit with the caveat that new data and research into 2019-nCoV is emerging and evolving at an explosive pace. Preliminary studies using molecular modeling and docking, and in that context the potential value of certain known herbal extracts, are also described.","Comput Biol Med","Robson, B","32209231"],"abstract":["This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19. This is to find a short section or sections of viral protein sequence suitable for preliminary design proposal for a peptide synthetic vaccine and a peptidomimetic therapeutic, and to explore some design possibilities. The project was originally directed towards a use case for the Q-UEL language and its implementation in a knowledge management and automated inference system for medicine called the BioIngine, but focus here remains mostly on the virus itself. However, using Q-UEL systems to access relevant and emerging literature, and to interact with standard publically available bioinformatics tools on the Internet, did help quickly identify sequences of amino acids that are well conserved across many coronaviruses including 2019-nCoV. KRSFIEDLLFNKV was found to be particularly well conserved in this study and corresponds to the region around one of the known cleavage sites of the SARS virus that are believed to be required for virus activation for cell entry. This sequence motif and surrounding variations formed the basis for proposing a specific synthetic vaccine epitope and peptidomimetic agent. The work can, nonetheless, be described in traditional bioinformatics terms, and readily reproduced by others, albeit with the caveat that new data and research into 2019-nCoV is emerging and evolving at an explosive pace. Preliminary studies using molecular modeling and docking, and in that context the potential value of certain known herbal extracts, are also described."],"journal":"Comput Biol Med","authors":["Robson, B"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32209231","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.compbiomed.2020.103670","keywords":["2019-ncov coronavirus","automatic browser","bioinformatics","peptidomimetic","q-uel language","retroinverso","synthetic vaccine","wuhan seafood market coronavirus"],"locations":["Q-UEL"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490545373185,"score":86.43961},{"pmid":32344166,"pmcid":"PMC7182753","title":"COVID-19 pandemic - A focused review for clinicians.","text":["COVID-19 pandemic - A focused review for clinicians.","BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.","Clin Microbiol Infect","Cevik, Muge","Bamford, Connor","Ho, Antonia","32344166"],"abstract":["BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality."],"journal":"Clin Microbiol Infect","authors":["Cevik, Muge","Bamford, Connor","Ho, Antonia"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344166","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.cmi.2020.04.023","keywords":["covid-19","sars-cov-2","coronavirus","novel coronavirus"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495831244800,"score":82.95251},{"pmid":32286607,"pmcid":"PMC7184353","title":"Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?","text":["Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?","Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease. The scientific community is actively and constantly working to identify the mechanisms involved in the diffusion of this virus and the pathogenesis of the infection, with its most frequent and severe complication, namely interstitial pneumonia. To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein. For this reason, the hypothesis that drugs capable of increasing the expression of this protein may have a role in the spread of the virus and in the symptomatology of affected patients has taken hold. The purpose of this Editorial is to briefly show the evidence currently available in this regard and to provide ideas for future research.","Eur Heart J Cardiovasc Pharmacother","Battistoni, Allegra","Volpe, Massimo","32286607"],"abstract":["Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease. The scientific community is actively and constantly working to identify the mechanisms involved in the diffusion of this virus and the pathogenesis of the infection, with its most frequent and severe complication, namely interstitial pneumonia. To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein. For this reason, the hypothesis that drugs capable of increasing the expression of this protein may have a role in the spread of the virus and in the symptomatology of affected patients has taken hold. The purpose of this Editorial is to briefly show the evidence currently available in this regard and to provide ideas for future research."],"journal":"Eur Heart J Cardiovasc Pharmacother","authors":["Battistoni, Allegra","Volpe, Massimo"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286607","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1093/ehjcvp/pvaa030","keywords":["hypertension","ras system","sars-cov-2"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138491312930817,"score":82.70578}]}